We are live on ! Find out more
ESLAW icon

Estrella Immunopharma Warrant
ESLAW

1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
 

About: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Healthcare Biotechnology

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 0%
Negative 0%

We haven’t received any recent news articles for ESLAW

See News Rankings
Price charts implemented using Lightweight Charts™